alphainsights
MarketsResearch
← Research

Infrastructure Developers & Operators · VATW

Va Tech Wabag Ltd

Water Treatment

Consensus target

2,410+21.7%

from 1,981 today

Firms
5
Calls
6
Latest
20 Aug 2026
5 Buy
Target by firm
1,981Motilal Oswal2,529IIFL2,455ICICI Securities2,410Systematix2,263Axis Securities2,105

6 published calls

  • SystematixBUY20 Aug 2026
    1,9812,263+14.2%

    We maintain BUY rating on all 3 coverage companies, VATW (TP Rs2,263), EIEL (Rs310) and JASH (Rs610).

  • ICICI SecuritiesBUY17 Aug 2026
    1,8902,410+27.5%

    Wabag reported a good set of numbers for Q1FY27 with revenue growing 21% and robust order inflows taking the order book to INR 194bn. We reiterate BUY with a revised target price of INR 2,410.

  • Motilal OswalBUY16 Aug 2026
    1,8902,529+33.8%

    VA Tech Wabag reported a strong and in-line operating performance in 1QFY27 with revenue growing 21% YoY, driven by robust order inflows and a strong order book of ~INR194b, providing strong revenue growth visibility for the next 3-4 years. We maintain our earnings estimates and reiterate our BUY rating.

  • Axis SecuritiesBUY14 Aug 2026
    1,8862,105+11.6%

    VA Tech Wabag reported a strong Q1FY27 driven by healthy execution, operating leverage, and a record order book of Rs 19,400 Cr ensuring multi-year revenue visibility, prompting us to maintain our BUY rating with a revised target price of Rs 2,105.

  • SystematixBUY14 Aug 2026
    1,8852,263+20.1%

    VA Tech Wabag reported strong Q1FY27 performance with revenue, EBITDA, and PAT beating estimates, supported by strong execution, robust international and industrial order books, and forex gains. We maintain our BUY rating with a revised target price of Rs 2,263 based on 24x FY28 EPS.

  • IIFLBUY10 Aug 2026
    2,0032,455+22.6%

    We initiate coverage on Va Tech Wabag (VATW) with BUY rating at 27x PE Sep’28. VATW, a century-old technology-first water treatment company is the world's third-largest desalination supplier, with 125+ proprietary technologies.

Ratings and target prices as published by each firm. Each summary condenses that firm's stated view in its own note and is attributed to it; no report text is reproduced.